Sunday November 8 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Astrocytoma

Astrocytomas are primary intracranial tumors derived from astrocytes cells of the brain. They may arise in the cerebral hemispheres, in the posterior fossa, in the optic nerve, and rarely, the spinal cord. The WHO has given a four point scale depending on the histologic grade of the tumor . This article focuses on the well-differentiated astrocytoma. For grade 1 and 4 astrocytomas, see respective article headings: (From the Wikpedia article Astrocytoma.)

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Astrocytoma:

Pubmed Logo
Factors Influencing Neurocognitive Outcomes in Young Patients with Benign and Low-Grade Brain Tumors Treated with Stereotactic Conformal Radiotherapy.
PURPOSE: To present the effect of radiotherapy doses to different volumes...
30th October, 2009
Department of Radiation Oncology, Tata Memorial Centre, Mumbai, India. Int J Radiat Oncol Biol Phys. 2009 Oct 26.
DOI Direct Link
Concurrent sequence variation of TP53 and TP73 genes in anaplastic astrocytoma.
Disruption or loss of tumor suppressor gene TP53 is implicated in the...
27th October, 2009
Departamento de Genetica, Laboratorio de Oncogenetica, Faculdade de Genet Mol Res. 2009 Oct 20;8(4):1257-63.
DOI Direct Link
Intrathecal liposomal cytarabine in combination with temozolomide in low-grade oligoastrocytoma with leptomeningeal dissemination.
Leptomeningeal dissemination of low-grade gliomas is an uncommon event. A...
27th October, 2009
Division of Neurology, USSL 22, Via Ospedale 6, 37012, Bussolengo, Verona, J Neurooncol. 2009 Oct 31.
DOI Direct Link
Caspase-dependent generation of reactive oxygen species in human astrocytoma cells contributes to resistance to TRAIL-mediated apoptosis.
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL), a...
27th October, 2009
Department of Bio and Brain Engineering, KAIST, Daejeon, Korea. Cell Death Differ. 2009 Oct 30.
DOI Direct Link
Nonenhancing Intramedullary Astrocytomas and Other MR Imaging Features: A Retrospective Study and Systematic Review.
BACKGROUND AND PURPOSE: Most intramedullary astrocytomas have been known...
27th October, 2009
Department of Radiology, Korea University Ansan Hospital, Kyunggi-do, AJNR Am J Neuroradiol. 2009 Oct 29.
DOI Direct Link

View more research publications.

Press Releases About Astrocytoma:

BioPortfolio Logo
Clinical Proof of Concept for TGF-beta 2-Inhibitor AP 12009 in Phase Iib EMEA provides Guidance on Phase III Design and Approval Requirements 2nd June, 2008 Antisense Pharma GmbH
CHICAGO and REGENSBURG, Germany, June 2 /PRNewswire/ -- "A two-year survival rate of more than 80 percent in recurrent or refractory anaplastic astrocytoma suggests a breakthrough in this

BioNews Results for Astrocytoma:

RSS Logo
BioPortfolio Logo
Caspase-dependent generation of reactive oxygen species in human astrocytoma cells contributes to resistance to TRAIL-mediated apoptosis
Cell Death and Differentiation:  Oct 30 2009 3:20PM Matching: astrocytoma
Mutation linked to pediatric brain tumor may pave way for targeted treatment
Washington University in St. Louis:  Oct 29 2009 10:24PM Matching: astrocytoma
Analysis of the mismatched manifestation between rCBF and rCBV maps in cerebral astrocytomas
Clinical Imaging:  Oct 28 2009 7:25AM Matching: astrocytoma
Health Canada approves Antisense Pharma's clinical Phase III study SAPPHIRE in aggressive brain tumors
Pharma Live:  Oct 20 2009 7:32AM Matching: astrocytoma
HK reports 32nd A/H1N1 flu death case
CHINAdaily:  Oct 20 2009 3:57PM Matching: astrocytoma
Promote your company here: BioNewsCast - Press Release Distribution

View more news.

Astrocytoma Clinical Trials:

Clinical Trials Logo
Effects of Vaccinations With HLA-A2-Restricted Glioma Antigen-Peptides in Combination With Poly-ICLC for Adults With High-Risk WHO Grade II Astrocytomas and Oligo-Astrocytomas

Astrocytoma Patents:

USPTO Logo
US Patent No.Title
7589119 Methods for treating or preventing metastatic cancer using benzopyranone compounds
7595320 Hydrazinocarbonyl-thieno[2,3-C]pyrazoles, process for preparing them, compositions containing them and use thereof
7595332 Amides that inhibit vanilloid receptor subtype 1 (VR1)
7595337 Mitotic kinesin inhibitors
7597884 Hyperglycosylated polypeptide variants and methods of use

View more patents.

Companies working in the area of Astrocytoma from Bioportfolio's Biocorporate database :

BioPortfolio Logo
Company Name

Protox Therapeutics Inc.

Protox Therapeutics is a product-focused development-stage company and a leader in advancing novel, targeted protein toxin therapeutics for the treatment of cancer and other proliferative diseases....
www.protoxtherapeutics.com/        View full profile
Thumbshot

BioPortfolio Ltd. offers e-mail and postal lists for Astrocytoma scientists - we have details of around 1338 individuals working on Astrocytoma .


This page has been viewed 838 times
Recent Search Terms used to find this page: GATA4 is a regulator of astrocyte cell proliferation | astrocytoma breakthrough gen therapy 2009 | astrocytoma drug discovery 2009 | Analysis of VEGF Flt-1 Flk-1 nestin and MMP-9 in relation to astrocytoma pathogenesis and progression pdf | Bull Cancer. 2009 May 1 96 5 579-589. | Bull Cancer. 2009 May 1 96 5 579-589. | astrocytoma drug discovery 2009 | astrocytoma drug discovery 2009 | discovery of astrocytoma | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Astrocytoma across BioPortfolio, or for Astrocytoma Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.